ALPHATON CAPITAL CORP.

NASDAQ: ATON (AlphaTON Capital Corp.)

Last update: 10 hours ago

1.65

-0.06 (-3.51%)

Previous Close 1.71
Open 1.65
Volume 237,649
Avg. Volume (3M) 1,516,428
Market Cap 12,583,705
Price / Book 9.34
52 Weeks Range
1.47 (-10%) — 15.82 (858%)
Earnings Date 8 Dec 2025

AIStockmoo Score

0.8
Analyst Consensus 0.0
Insider Activity NA
Price Volatility 3.0
Technical Moving Averages 2.5
Technical Oscillators -2.5
Average 0.75

Ownership

Name Date Shares Held
Bison Wealth, Llc 31 Dec 2024 19,272
Qtr Family Wealth, Llc 30 Sep 2025 19,272
Princeton Global Asset Management Llc 30 Sep 2025 8
Credit Agricole S A 30 Sep 2025 0
Cwm, Llc 30 Sep 2025 0
Date Type Details
05 Dec 2025 Announcement AlphaTON Capital to Reveal 2026 Technical Strategy in Landmark Inaugural AMA Event
05 Dec 2025 Announcement AlphaTON Capital to Reveal 2026 Technical Strategy in Landmark Inaugural AMA Event
04 Dec 2025 Announcement AlphaTON Capital Exits SEC “Baby-Shelf Rules” and Files $420.69 Million Shelf Registration Statement
01 Dec 2025 Announcement AlphaTON Capital Successfully Deploys First Fleet of Nvidia B200 GPUs to Telegram's Cocoon AI Network, Powering Privacy-First AI for One Billion Users
26 Nov 2025 Announcement AlphaTON Capital Secures $82.5 Million Strategic GPU Infrastructure to Power Privacy-First Decentralized Artificial Intelligence Cluster after Successful Pilot Launch of Telegram’s Cocoon AI
26 Nov 2025 Announcement AlphaTON Capital Announces $82.5 Million Strategic GPU Infrastructure Investment to Power Privacy-First Decentralized AI after Successful Pilot Launch of Telegram’s Cocoon AI
25 Nov 2025 Announcement AlphaTON Capital Corp. to Accumulate Telegram Bonds for its Treasury
24 Nov 2025 Announcement AlphaTON Capital Submits Strategic Offer to Acquire Majority Stake in Forbes Media Holdings
20 Nov 2025 Announcement AlphaTON Capital (Nasdaq: ATON) Issues Shareholder Update on Balance Sheet Assets and Strategic Ecosystem Expansion Clarification and Correction
20 Nov 2025 Announcement AlphaTON Bolsters Tech Leadership with New CTO to Drive AI Growth
19 Nov 2025 Announcement AlphaTON Capital (Nasdaq: ATON) Issues Shareholder Update on Balance Sheet Assets and Strategic Ecosystem Expansion
17 Nov 2025 Announcement AlphaTON Capital Selects P2P.org as First Institutional Staking Partner for TON Treasury Operations
17 Nov 2025 Announcement AlphaTON Capital Names P2P.org as Institutional Staking Partner to Accelerate TON Treasury Yield Strategy
13 Nov 2025 Announcement AlphaTON Capital and SingularityNET Join Forces to Accelerate Telegram’s Cocoon AI – Growing the Ethical, Decentralized AI Ecosystem
12 Nov 2025 Announcement AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans
11 Nov 2025 Announcement AlphaTON Capital Accelerates Global Growth with Strategic Appointment of William De’Ath as Chief Partnership Officer
11 Nov 2025 Announcement AlphaTON Capital Accelerates Global Growth with Strategic Appointment of William De’Ath as Chief Partnership Officer
07 Nov 2025 Announcement Complete Tumor Regressions Observed in Preclinical Models with Co-administration of Cyncado’s A2B and A2A Receptor Antagonists and Cancer Vaccines
05 Nov 2025 Announcement AlphaTON Capital to Acquire Premier Crypto Newswire Blockchain Wire, Cementing Dominance in Digital Asset Communications via the Telegram Ecosystem
04 Nov 2025 Announcement DAT ALERT: AlphaTON Capital Acquires 300,000 additional TON
03 Nov 2025 Announcement AlphaTON Capital Corp Announces Strategic Joint Venture with Pago Pay and with ALT5 Sigma to Launch Crypto-Enabled TON Mastercard
03 Nov 2025 Announcement Brittany Kaiser to Present at SALT London 2025 on DeFi, Tokenization, and Digital Asset Treasuries
03 Nov 2025 Announcement AlphaTON Capital Takes Center Stage at TRUST Summit 2025 to Shape the Future of Digital Finance
31 Oct 2025 Announcement AlphaTON Capital Kicks Off Global World Tour with Investor Breakfast at Nasdaq MarketSite
29 Oct 2025 Announcement AlphaTON Capital Announces Strategic Investment in GPU Infrastructure to Power Cocoon Decentralized AI Network
27 Oct 2025 Announcement AlphaTON Capital CEO Brittany Kaiser to Speak at “Future of Money, Governance, and the Law” Summit on Capitol Hill, October 30, 2025
27 Oct 2025 Announcement AlphaTON (Nasdaq:ATON) and Cyncado Therapeutics: Preclinical Mesothelioma Data Show Direct A2B Tumor Activity; TT-4 Achieved >90% Tumor Growth Inhibition; First-Patient Dosing on Track for Q1 2026
25 Oct 2025 Announcement AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4’s Path to First- Patient Dosing
24 Oct 2025 Announcement AlphaTON Capital Appoints Wes Levitt as Chief Financial Officer
22 Oct 2025 Announcement AlphaTON Capital Joins Blockchain Game Alliance (BGA)
22 Oct 2025 Announcement AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth
20 Oct 2025 Announcement Enzo Villani, Chief Investment Officer of AlphaTON Capital, to Speak at the Vatican’s 10th Anniversary World Changers Summit
15 Oct 2025 Announcement AlphaTON Capital Powers TOKEN2049 “Origins” Hackathon in Singapore
14 Oct 2025 Announcement AlphaTON Capital CEO Brittany Kaiser and SkyBridge Capital Founder Anthony Scaramucci Join Schwab Network’s Trading 360 to Discuss Crypto Innovation and Cancer Research Funding
13 Oct 2025 Announcement AlphaTON Capital Launches AI Vertical with MorpheusAI to Accelerate Agentic AI Development on TON and Telegram
12 Oct 2025 Announcement Market Alert: AlphaTON Capital Continues in Growth Mode and Purchases an additional 300,000 TON
10 Oct 2025 Announcement AlphaTON Capital Receives Nasdaq Congratulations for Groundbreaking Cancer Research Tokenization Initiative
09 Oct 2025 Announcement AlphaTON Capital CIO and Executive Chairman Enzo Villani Featured in Live Interview at Nasdaq MarketSite with IPO Edge
08 Oct 2025 Announcement AlphaTON Capital and Subsidiary Cyncado Therapeutics Pioneer Convergence of Digital Assets and Oncology Innovation: Exploring Tokenization Framework for Mesothelioma Program as it Advances Toward Q1 2026 First Patient Dosing
30 Sep 2025 Announcement Health In Tech and AlphaTON Capital Sign Strategic Letter of Intent to Develop HITChain
25 Sep 2025 Announcement AlphaTON Capital Corp Successfully Closes $71 million Financing and Completes Initial TON Token Acquisition
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria